In Vitro Neurotoxicity Testing

Anon. (1994). ECVAM News & Views. ATLA 22, 7–11.

Anon (1991). Pesticide assessment guidelines, subdivision F. Hazard evaluation: human domestic animals. NTIS Springfield, VA, USA: EPA. PB 91–154617.

O'Callaghan J.P. , and Jensen K.C. (1992). Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity. Neurotoxicology 13, 113–122.

Cookson M.R. , and Pentreath V.W. (1994). Alterations in the glial fibrillary acidic protein content of primary astrocyte cultures for evaluation of glial cell toxicity. Toxicology in Vitro 8, 351–359.

Veronesi B. (1992). In vitro screening batteries for neurotoxicants. Neurotoxicology 13, 185–196.

Dewar A.J. (1983). Neurotoxicity. In Animals and Alternatives in Toxicity Testing (ed. Balls M. , Riddell R.J , & Worden A.N. ), pp. 229–284. London: Academic Press.

Atterwill C.K. , Simpson M.G. , Evans R.J. , Allen S.L. , and Ray D. (1991). Alternative methods and their application in neurotoxicity testing. In Animals and Alternatives in Toxicology: Present Status and Future Prospects (ed. Balls M. , Bridges J. , Southee J. ), pp. 121–152. Basingstoke: Macmillan Press.

Atterwill C.K. (1989). Brain reaggregate cultures in neurotoxicological investigations: studies with cholinergic neurotoxins. ATLA 16, 221–230.

Walum E. , Nordin M. , Beckman M. , and Odland L. (1993). Cellular methods for identification of neurotoxic chemicals and estimation of neurotoxicological risk. Toxicology in Vitro 7, 321–326.

Anon. (1992). Neurotoxicology and Models for Assessing Risk for Neu and Existing Chemicals (National Research Council [USA] Committee Report), 153 pp. Washington, DC: National Academy Press.

Atterwill C.K. , Davenport-Jones J. , Goonetilleke S. , Johnston H. , Purcell W. , Thomas S.M. , West M. , and Williams S. (1993). New models for the in vitro assessment of neurotoxicity in the nervous system and the preliminary validation stages of a “tiered-test” model. Toxicology in Vitro 7, 569–580.

Williams S.P. , Davenport-Jones J. , Egan C. , O'Hare S. , Cookson M. , McClean R. , Garle M.J. , Pentreath V. , and Atterwill C.K. (1994). Phase I of an in vitro neurotoxicological validation trial. Toxicology in Vitro, in press.

Walum E. , Balls M. , Bianchi V. , Blaauboer B. , Bolcsfoldi G. , Guillouzo A. , Moore G.A. , Odland L. , Reinhardt C.A. , and Spielmann H. (1992). ECITTS: an integrated approach to the application of in vitro systems to the hazard assessment of chemicals. ATLA 20, 406–428.

Williams C. (1993). Biotechnology Programme: sectoral meeting on in vitro evaluation of the toxicity and pharmacological activity of molecules (conference report). ATLA 21, 386–388.

Rodríguez-Farré E. , Roberfroid M. , and Fracchia G.N. (1993). Research and development of in vitro pharmaeotoxicology: a European perspective. ATLA 21, 285–293.

Purcell W.M. , and Atterwill C.K. (1994). Human placental mast cells as an in vitro model system in aspects of neuroimmunotoxicity testing. Human and Experimental Toxicology 13, 429–434.